Tue, December 10, 2019
Mon, December 9, 2019
Fri, December 6, 2019
Thu, December 5, 2019
Wed, December 4, 2019
Tue, December 3, 2019
Mon, December 2, 2019
Fri, November 29, 2019
Wed, November 27, 2019
Tue, November 26, 2019
Mon, November 25, 2019
Fri, November 22, 2019
Thu, November 21, 2019
Wed, November 20, 2019
Tue, November 19, 2019

Gena Wang Upgraded (BMRN) to Buy and Held Target at $98 on, Nov 27th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-98-on-nov-27th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gena Wang of Barclays, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Buy and Held Target at $98 on, Nov 27th, 2019.

Gena has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Gena


  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $95 on, Wednesday, October 30th, 2019
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $108 on, Monday, October 28th, 2019
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $152 on, Friday, October 25th, 2019

Publication Contributing Sources